Web Stats Provided By Google Analytics

Monday, January 27, 2014

At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt

As Gilead Sciences Inc. touted its $1,000-a-pill hepatitis C cure to investors in a hotel ballroom in San Francisco last week, a group of about 20 protesters milled outside.

http://ift.tt/1eZM1BB
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)